Management and Outcome of Mesh Infection After Abdominoplasty in a Tertiary Care Centre

Completed

• Conditions: Abdominal Infection

• Registration Number: NCT06682091
• Lead Sponsor: Hospices Civils de Lyon

Brief Summary

Hernia repair is among most frequent surgical interventions. The use of abdominal mesh in hernia repair has become the Gold Standard strategy, reducing the risk of relapse.

The mesh infection risk is estimated lower than 1% in simple situations, but can increase up to 20% in complicated patients. Risk factors are well known, but we lack data regarding the therapeutic strategies and outcomes.

This study aims to describe the characteristics and management of abdominal mesh infections, and the related outcomes.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-01-01
• Primary Completion: 2023-01-01
• Study Completion: 2023-01-01
• Study First Submitted: 2024-06-07
• Status Verified: 2024-11
• Study First Submitted QC: 2024-11-08
• Last Update Submitted: 2024-11-08
• Study First Posted: 2024-11-11
• Last Update Posted: 2024-11-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 209

Inclusion Criteria

• parietal mesh infection
• age > 18

Exclusion Criteria

• Non French speaking patients.
• Persons under tutorship or curatorship.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Treatment failure.	Retrospective analysis from initial treatment to any treatment failure within 2010 to 2023	Clinical failure = persistance of the infection. Time of failure is the time of change of therapeutic strategy.

Trial Locations

Locations (1)

Hospices Civils de Lyon - Hopital de la Croix Rousse - Centre de reference des infection ostéo-articulaires de Lyon; 🇫🇷 Lyon, France